The Complex Interaction Between Methamphetamine Abuse and HIV-1 Pathogenesis

Journal of Neuroimmune Pharmacology

Volumn 10, Issue 3, 2015, Pages 477-486

  Passaro, Ryan Colby ^a   Pandhare, Jui ^b   Qian, Han Zhu ^a   Dash, Chandravanu ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

AIDS; CD4+ T cells; HIV; Methamphetamine

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; INTERLEUKIN 1BETA; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; METHAMPHETAMINE; MITOGEN ACTIVATED PROTEIN KINASE P38; RANTES;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DISEASE COURSE; DISEASE TRANSMISSION; DRUG ABUSE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOMODULATION; IMMUNOPATHOLOGY; LIFESTYLE; MEN WHO HAVE SEX WITH MEN; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SEXUAL BEHAVIOR; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; VIRAL GENETICS; VIRUS CULTURE; VIRUS LOAD; VIRUS REPLICATION; AMPHETAMINE DEPENDENCE; ANIMAL; COMPLICATION; DRUG EFFECTS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATHOGENICITY; PATHOPHYSIOLOGY;

AMPHETAMINE-RELATED DISORDERS; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; HIV INFECTIONS; HIV-1; HUMANS; METHAMPHETAMINE;

EID: 84939564098     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-015-9604-2     Document Type: Article

References (64)

1. Arnsten JH, Demas PA, Grant RW, Gourevitch MN, Farzadegan H et al (2002) Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med 17:377–381
2. Cachay ER, Moini N, Kosakovsky Pond SL, Pesano R, Lie YS et al (2007) Active methamphetamine use is associated with transmitted drug resistance to non-nucleoside reverse transcriptase inhibitors in individuals with HIV infection of unknown duration. Open AIDS J 1:5–10
3. Carrico AW, Johnson MO, Moskowitz JT, Neilands TB, Morin SF et al (2007) Affect regulation, stimulant use, and viral load among HIV-positive persons on anti-retroviral therapy. Psychosom Med 69:785–792
4. Carrico AW, Johnson MO, Colfax GN, Moskowitz JT (2010) Affective correlates of stimulant use and adherence to anti-retroviral therapy among HIV-positive methamphetamine users. AIDS Behav 14:769–777
5. CDC (2012) HIV Surveillance Report,. http://www.cdc.gov/hiv/topics/surveillance/resources/22
6. Chaturvedi S, Frame P, Newman SL (1995) Macrophages from human immunodeficiency virus-positive persons are defective in host defense against Histoplasma capsulatum. J Infect Dis 171:320–327
7. Cisneros IE, Ghorpade A (2012) HIV-1, methamphetamine and astrocyte glutamate regulation: combined excitotoxic implications for neuro-AIDS. Curr HIV Res 10:392–406
8. Colfax G, Shoptaw S (2005) The methamphetamine epidemic: implications for HIV prevention and treatment. Curr HIV/AIDS Rep 2:194–199
9. Colfax G, Coates TJ, Husnik MJ, Huang Y, Buchbinder S et al (2005) Longitudinal patterns of methamphetamine, popper (amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of San Francisco men who have sex with men. J Urban Health 82:i62–70
10. Drumright LN, Little SJ, Strathdee SA, Slymen DJ, Araneta MR et al (2006) Unprotected anal intercourse and substance use among men who have sex with men with recent HIV infection. J Acquir Immune Defic Syndr 43:344–350
11. Eissenberg LG, Goldman WE, Schlesinger PH (1993) Histoplasma capsulatum modulates the acidification of phagolysosomes. J Exp Med 177:1605–1611
12. Ellis RJ, Childers ME, Cherner M, Lazzaretto D, Letendre S et al (2003) Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis 188:1820–1826
13. Everall I, Salaria S, Roberts E, Corbeil J, Sasik R et al (2005) Methamphetamine stimulates interferon inducible genes in HIV infected brain. J Neuroimmunol 170:158–171
14. Fairbairn N, Kerr T, Milloy MJ, Zhang R, Montaner J et al (2011) Crystal methamphetamine injection predicts slower HIV RNA suppression among injection drug users. Addict Behav 36:762–763
15. Friedman H, Pross S, Klein TW (2006) Addictive drugs and their relationship with infectious diseases. FEMS Immunol Med Microbiol 47:330–342
16. Gaskill PJ, Calderon TM, Coley JS, Berman JW (2013) Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND. J Neuroimmune Pharmacol 8:621–642
17. Gavrilin MA, Mathes LE, Podell M (2002) Methamphetamine enhances cell-associated feline immunodeficiency virus replication in astrocytes. J Neurovirol 8:240–249
18. Gruenewald PJ, Johnson FW, Ponicki WR, Remer LG, Lascala EA (2010) Assessing correlates of the growth and extent of methamphetamine abuse and dependence in California. Subst Use Misuse 45:1948–1970
19. Halkitis PN, Parsons JT, Stirratt MJ (2001) A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men. J Homosex 41:17–35
20. Harms R, Morsey B, Boyer CW, Fox HS, Sarvetnick N (2012) Methamphetamine administration targets multiple immune subsets and induces phenotypic alterations suggestive of immunosuppression. PLoS One 7:e49897
21. Hinkin CH, Barclay TR, Castellon SA, Levine AJ, Durvasula RS et al (2007) Drug use and medication adherence among HIV-1 infected individuals. AIDS Behav 11:185–194
22. http://www.who.int/mediacentre/factsheets/fs360/en/index.html
23. Hurt CB, Torrone E, Green K, Foust E, Leone P et al (2010) Methamphetamine use among newly diagnosed HIV-positive young men in North Carolina, United States, from 2000 to 2005. PLoS One 5:e11314
24. In SW, Son EW, Rhee DK, Pyo S (2004) Modulation of murine macrophage function by methamphetamine. J Toxicol Environ Health A 67:1923–1937
25. King WD, Larkins S, Hucks-Ortiz C, Wang PC, Gorbach PM et al (2009) Factors associated with HIV viral load in a respondent driven sample in Los Angeles. AIDS Behav 13:145–153
26. Kipp AM, Desruisseau AJ, Qian HZ (2011) Non-injection drug use and HIV disease progression in the era of combination antiretroviral therapy. J Subst Abuse Treat 40:386–396
27. Lane HC (2010) Pathogenesis of HIV infection: total CD4+ T-cell pool, immune activation, and inflammation. Top HIV Med 18:2–6
28. Liang H, Wang X, Chen H, Song L, Ye L et al (2008) Methamphetamine enhances HIV infection of macrophages. Am J Pathol 172:1617–1624
29. Loftis JM, Choi D, Hoffman W, Huckans MS (2011) Methamphetamine causes persistent immune dysregulation: a cross-species, translational report. Neurotox Res 20:59–68
30. Mahajan SD, Hu Z, Reynolds JL, Aalinkeel R, Schwartz SA et al (2006) Methamphetamine modulates gene expression patterns in monocyte derived mature dendritic cells: implications for HIV-1 pathogenesis. Mol Diagn Ther 10:257–269
31. Mansergh G, Shouse RL, Marks G, Guzman R, Rader M et al (2006) Methamphetamine and sildenafil (Viagra) use are linked to unprotected receptive and insertive anal sex, respectively, in a sample of men who have sex with men. Sex Transm Infect 82:131–134
32. Mantri CK, Mantri JV, Pandhare J, Dash C (2014) Methamphetamine inhibits HIV-1 replication in CD4+ T cells by modulating anti-HIV-1 miRNA expression. Am J Pathol 184:92–100
33. Marcondes MC, Flynn C, Watry DD, Zandonatti M, Fox HS (2010) Methamphetamine increases brain viral load and activates natural killer cells in simian immunodeficiency virus-infected monkeys. Am J Pathol 177:355–361
34. Markowitz M, Mohri H, Mehandru S, Shet A, Berry L et al (2005) Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report. Lancet 365:1031–1038
35. Marquez C, Mitchell SJ, Hare CB, John M, Klausner JD (2009) Methamphetamine use, sexual activity, patient-provider communication, and medication adherence among HIV-infected patients in care, San Francisco 2004–2006. AIDS Care 21:575–582
36. Martinez LR, Mihu MR, Gacser A, Santambrogio L, Nosanchuk JD (2009) Methamphetamine enhances histoplasmosis by immunosuppression of the host. J Infect Dis 200:131–141
37. Misawa F, Shimizu K, Fujii Y, Miyata R, Koshiishi F et al (2011) Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects?: a cross-sectional study. BMC Psychiatry 11:118
38. Nair MP, Saiyed ZM (2011) Effect of methamphetamine on expression of HIV coreceptors and CC-chemokines by dendritic cells. Life Sci 88:987–994
39. Nair MP, Samikkannu T (2012) Differential regulation of neurotoxin in HIV clades: role of cocaine and methamphetamine. Curr HIV Res 10:429–434
40. Nair MP, Mahajan S, Sykes D, Bapardekar MV, Reynolds JL (2006) Methamphetamine modulates DC-SIGN expression by mature dendritic cells. J Neuroimmune Pharmacol 1:296–304
41. Nair MP, Saiyed ZM, Nair N, Gandhi NH, Rodriguez JW et al (2009) Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells. J Neuroimmune Pharmacol 4:129–139
42. Newman SL (1999) Macrophages in host defense against Histoplasma capsulatum. Trends Microbiol 7:67–71
43. Parsons JT, Kowalczyk WJ, Botsko M, Tomassilli J, Golub SA (2013) Aggregate versus day level association between methamphetamine use and HIV medication non-adherence among gay and bisexual men. AIDS Behav 17:1478–1487
44. Patterson TL, Semple SJ, Staines H, Lozada R, Orozovich P et al (2008) Prevalence and correlates of HIV infection among female sex workers in 2 Mexico-US border cities. J Infect Dis 197:728–732
45. Peck JA, Reback CJ, Yang X, Rotheram-Fuller E, Shoptaw S (2005) Sustained reductions in drug use and depression symptoms from treatment for drug abuse in methamphetamine-dependent gay and bisexual men. J Urban Health 82:i100–108
46. Pelchen-Matthews A, Kramer B, Marsh M (2003) Infectious HIV-1 assembles in late endosomes in primary macrophages. J Cell Biol 162:443–455
47. Plankey MW, Ostrow DG, Stall R, Cox C, Li X et al (2007) The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 45:85–92
48. Potula R, Persidsky Y (2008) Adding fuel to the fire: methamphetamine enhances HIV infection. Am J Pathol 172:1467–1470
49. Qian HZ, McGowan CC, Mitchell VJ, Cassell H, Perez G, et al (2011) Non-injection substance abuse, depression, and adherence to antiretroviral therapy among HIV-infected patients. Rome, Italy
50. Rawson RA, Anglin MD, Ling W (2002) Will the methamphetamine problem go away? J Addict Dis 21:5–19
51. Reback CJ, Larkins S, Shoptaw S (2003) Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. AIDS Care 15:775–785
52. Reiner BC, Keblesh JP, Xiong H (2009) Methamphetamine abuse, HIV infection, and neurotoxicity. Int J Physiol Pathophysiol Pharmacol 1:162–179
53. Semple SJ, Patterson TL, Grant I (2002) Motivations associated with methamphetamine use among HIV+ men who have sex with men. J Subst Abuse Treat 22:149–156
54. Shoptaw S, Reback CJ (2006) Associations between methamphetamine use and HIV among men who have sex with men: a model for guiding public policy. J Urban Health 83:1151–1157
55. Shoptaw S, Stall R, Bordon J, Kao U, Cox C et al (2012) Cumulative exposure to stimulants and immune function outcomes among HIV-positive and HIV-negative men in the multicenter AIDS cohort study. Int J STD AIDS 23:576–580
56. Sun J, Soos T, Kewalramani VN, Osiecki K, Zheng JH et al (2006) CD4-specific transgenic expression of human cyclin T1 markedly increases human immunodeficiency virus type 1 (HIV-1) production by CD4+ T lymphocytes and myeloid cells in mice transgenic for a provirus encoding a monocyte-tropic HIV-1 isolate. J Virol 80:1850–1862
57. Talloczy Z, Martinez J, Joset D, Ray Y, Gacser A et al (2008) Methamphetamine inhibits antigen processing, presentation, and phagocytosis. PLoS Pathog 4:e28
58. Thiede H, Valleroy LA, MacKellar DA, Celentano DD, Ford WL et al (2003) Regional patterns and correlates of substance use among young men who have sex with men in 7 US urban areas. Am J Public Health 93:1915–1921
59. Toussi SS, Joseph A, Zheng JH, Dutta M, Santambrogio L et al (2009) Short communication: methamphetamine treatment increases in vitro and in vivo HIV replication. AIDS Res Hum Retroviruses 25:1117–1121
60. Walensky RP, Paltiel AD, Losina E, Mercincavage LM, Schackman BR et al (2006) The survival benefits of AIDS treatment in the United States. J Infect Dis 194:11–19
61. Wang X, Ho WZ (2011) Drugs of abuse and HIV infection/replication: implications for mother-fetus transmission. Life Sci 88:972–979
62. Wires ES, Alvarez D, Dobrowolski C, Wang Y, Morales M et al (2012) Methamphetamine activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB) and induces human immunodeficiency virus (HIV) transcription in human microglial cells. J Neurovirol 18:400–410
63. Wohl AR, Johnson DF, Lu S, Jordan W, Beall G et al (2002) HIV risk behaviors among African American men in Los Angeles county who self-identify as heterosexual. J Acquir Immune Defic Syndr 31:354–360
64. Yu Q, Zhang D, Walston M, Zhang J, Liu Y et al (2002) Chronic methamphetamine exposure alters immune function in normal and retrovirus-infected mice. Int Immunopharmacol 2:951–962